GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Entero Healthcare Solutions Ltd

Entero Healthcare: Director Rajesh Dalal to cease by August 24, 2026

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 13 Jul 2026, 06:30 PM IST  ·  BSE ID: 090d4248-d802-4723-b58a-cc9b9a8dc79b
View Original BSE Filing (PDF)
💡
In Simple Terms
A company director is stepping down next month after his current term ends, as he is not seeking reappointment.
🤖 AI Summary
  • Rajesh Shashikant Dalal ceases as Non-Executive Independent Director.
  • Cessation effective August 24, 2026, upon completion of his first term.
  • He will also step down as Chairperson of Nomination Committee and Stakeholders Committee.
  • Mr. Dalal will cease membership of the Audit Committee of the Board.
🏢 How This Affects the Company
⚙️
Operational Impact
The company will need to appoint a new Non-Executive Independent Director and potentially fill committee leadership roles.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this director's cessation.
👤
Who Is Affected
All shareholders are indirectly affected by changes in board composition and committee leadership.
🔍
Management Signal
This signals a planned transition in directorship and committee assignments as per standard tenure practices.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Board meeting announcement for new director appointments.
Disclosure of Mr. Dalal's replacement on committees.
Next quarterly results announcement for overall company performance.
LOW RISK This is a routine cessation of a director upon term expiry, with advance notice.
💡 Investor Takeaway
Mr. Rajesh Shashikant Dalal is ceasing his role as Non-Executive Independent Director and committee chair/member effective August 24, 2026, having decided not to seek reappointment.
❓ Frequently Asked Questions
When will Mr. Rajesh Shashikant Dalal cease to be a director at Entero Healthcare?
Mr. Rajesh Shashikant Dalal will cease to be a Non-Executive Independent Director of Entero Healthcare Solutions at the close of business hours on August 24, 2026.
Why is Mr. Rajesh Shashikant Dalal leaving Entero Healthcare's board?
Mr. Dalal informed the Board of his decision not to seek reappointment for a second term upon completion of his first term.
Will Mr. Rajesh Shashikant Dalal continue in committee roles?
No, Mr. Dalal will cease to be the Chairperson of the Nomination and Remuneration Committee and the Stakeholders Relationship Committee, and a member of the Audit Committee.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.